View in EDS

Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Saved in:
Bibliographic Details
Title: Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.
Authors: Czernilofsky F; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Mathioudaki A; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Division of AI in Oncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Jopp-Saile L; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Charité Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany., Lutz R; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Vonficht D; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Wang X; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Schniederjohann C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Voehringer H; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Roider T; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Baertsch MA; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Rodemer C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Löffler-Wirth H; Interdisciplinary Centre for Bioinformatics (IZBI), University of Leipzig, Leipzig, Germany., Grau M; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Fitzgerald D; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany., Mammen J; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Kosla J; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic., Liebers N; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Bruch PM; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Ordoñez-Rueda D; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Brobeil A; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Mechtersheimer G; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Pabst C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Müller-Tidow C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Seifert M; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany., Neumann F; Kite, a Gilead Company, Santa Monica, CA, USA., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany., Benes V; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Huber W; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Distler J; Department of Rheumatology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany., Lenz G; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Binder H; Interdisciplinary Centre for Bioinformatics (IZBI), University of Leipzig, Leipzig, Germany., Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Nolan GP; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Gerstung M; Division of AI in Oncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Zaugg JB; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. judith.zaugg@unibas.ch.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany. judith.zaugg@unibas.ch.; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland. judith.zaugg@unibas.ch., Hübschmann D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Division of Translational Precision Medicine, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de., Haas S; Berlin Institute of Health (BIH), Charité Universitätsmedizin Berlin, Berlin, Germany. simon.haas@bih-charite.de.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany. simon.haas@bih-charite.de.; German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany. simon.haas@bih-charite.de.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK. simon.haas@bih-charite.de.; Cluster of Excellence ImmunoPreCept, Charité Universitätsmedizin Berlin, Berlin, Germany. simon.haas@bih-charite.de., Dietrich S; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany. sascha.dietrich@embl.de.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. sascha.dietrich@embl.de.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany. sascha.dietrich@embl.de.; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany. sascha.dietrich@embl.de.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany. sascha.dietrich@embl.de.
Source: Nature cancer [Nat Cancer] 2026 Mar; Vol. 7 (3), pp. 538-552. Date of Electronic Publication: 2026 Mar 25.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41882179
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Czernilofsky+F%22">Czernilofsky F</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mathioudaki+A%22">Mathioudaki A</searchLink>; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Division of AI in Oncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jopp-Saile+L%22">Jopp-Saile L</searchLink>; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Berlin Institute of Health (BIH), Charité Universitätsmedizin Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lutz+R%22">Lutz R</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Vonficht+D%22">Vonficht D</searchLink>; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schniederjohann+C%22">Schniederjohann C</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Voehringer+H%22">Voehringer H</searchLink>; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Roider+T%22">Roider T</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Baertsch+MA%22">Baertsch MA</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rodemer+C%22">Rodemer C</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Löffler-Wirth+H%22">Löffler-Wirth H</searchLink>; Interdisciplinary Centre for Bioinformatics (IZBI), University of Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Grau+M%22">Grau M</searchLink>; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+D%22">Fitzgerald D</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mammen+J%22">Mammen J</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Kosla+J%22">Kosla J</searchLink>; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.; Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Liebers+N%22">Liebers N</searchLink>; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Bruch+PM%22">Bruch PM</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Ordoñez-Rueda+D%22">Ordoñez-Rueda D</searchLink>; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Brobeil+A%22">Brobeil A</searchLink>; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mechtersheimer+G%22">Mechtersheimer G</searchLink>; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Pabst+C%22">Pabst C</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Trumpp+A%22">Trumpp A</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Seifert+M%22">Seifert M</searchLink>; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Neumann+F%22">Neumann F</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Heikenwälder+M%22">Heikenwälder M</searchLink>; Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Benes+V%22">Benes V</searchLink>; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Huber+W%22">Huber W</searchLink>; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Distler+J%22">Distler J</searchLink>; Department of Rheumatology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Lenz+G%22">Lenz G</searchLink>; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Binder+H%22">Binder H</searchLink>; Interdisciplinary Centre for Bioinformatics (IZBI), University of Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Siebert+R%22">Siebert R</searchLink>; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Nolan+GP%22">Nolan GP</searchLink>; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gerstung+M%22">Gerstung M</searchLink>; Division of AI in Oncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Zaugg+JB%22">Zaugg JB</searchLink>; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. judith.zaugg@unibas.ch.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany. judith.zaugg@unibas.ch.; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland. judith.zaugg@unibas.ch.<br /><searchLink fieldCode="AU" term="%22Hübschmann+D%22">Hübschmann D</searchLink>; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Division of Translational Precision Medicine, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Haas+S%22">Haas S</searchLink>; Berlin Institute of Health (BIH), Charité Universitätsmedizin Berlin, Berlin, Germany. simon.haas@bih-charite.de.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany. simon.haas@bih-charite.de.; German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany. simon.haas@bih-charite.de.; Precision Healthcare University Research Institute, Queen Mary University of London, London, UK. simon.haas@bih-charite.de.; Cluster of Excellence ImmunoPreCept, Charité Universitätsmedizin Berlin, Berlin, Germany. simon.haas@bih-charite.de.<br /><searchLink fieldCode="AU" term="%22Dietrich+S%22">Dietrich S</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany. sascha.dietrich@embl.de.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. sascha.dietrich@embl.de.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany. sascha.dietrich@embl.de.; Department of Hematology, Oncology and Clinical Immunology, Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Germany. sascha.dietrich@embl.de.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany. sascha.dietrich@embl.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2026 Mar; Vol. 7 (3), pp. 538-552. <i>Date of Electronic Publication: </i>2026 Mar 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41882179
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43018-026-01136-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 538
    Titles:
      – TitleFull: Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Czernilofsky F
      – PersonEntity:
          Name:
            NameFull: Mathioudaki A
      – PersonEntity:
          Name:
            NameFull: Jopp-Saile L
      – PersonEntity:
          Name:
            NameFull: Lutz R
      – PersonEntity:
          Name:
            NameFull: Vonficht D
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Schniederjohann C
      – PersonEntity:
          Name:
            NameFull: Voehringer H
      – PersonEntity:
          Name:
            NameFull: Roider T
      – PersonEntity:
          Name:
            NameFull: Baertsch MA
      – PersonEntity:
          Name:
            NameFull: Rodemer C
      – PersonEntity:
          Name:
            NameFull: Löffler-Wirth H
      – PersonEntity:
          Name:
            NameFull: Grau M
      – PersonEntity:
          Name:
            NameFull: Fitzgerald D
      – PersonEntity:
          Name:
            NameFull: Mammen J
      – PersonEntity:
          Name:
            NameFull: Kosla J
      – PersonEntity:
          Name:
            NameFull: Liebers N
      – PersonEntity:
          Name:
            NameFull: Bruch PM
      – PersonEntity:
          Name:
            NameFull: Ordoñez-Rueda D
      – PersonEntity:
          Name:
            NameFull: Brobeil A
      – PersonEntity:
          Name:
            NameFull: Mechtersheimer G
      – PersonEntity:
          Name:
            NameFull: Pabst C
      – PersonEntity:
          Name:
            NameFull: Müller-Tidow C
      – PersonEntity:
          Name:
            NameFull: Trumpp A
      – PersonEntity:
          Name:
            NameFull: Seifert M
      – PersonEntity:
          Name:
            NameFull: Neumann F
      – PersonEntity:
          Name:
            NameFull: Heikenwälder M
      – PersonEntity:
          Name:
            NameFull: Benes V
      – PersonEntity:
          Name:
            NameFull: Huber W
      – PersonEntity:
          Name:
            NameFull: Distler J
      – PersonEntity:
          Name:
            NameFull: Lenz G
      – PersonEntity:
          Name:
            NameFull: Binder H
      – PersonEntity:
          Name:
            NameFull: Siebert R
      – PersonEntity:
          Name:
            NameFull: Nolan GP
      – PersonEntity:
          Name:
            NameFull: Gerstung M
      – PersonEntity:
          Name:
            NameFull: Zaugg JB
      – PersonEntity:
          Name:
            NameFull: Hübschmann D
      – PersonEntity:
          Name:
            NameFull: Haas S
      – PersonEntity:
          Name:
            NameFull: Dietrich S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2662-1347
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Nature cancer
              Type: main
ResultId 1